Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma. | UCSF Helen Diller Family Comprehensive Cancer Center

Author List

Han SJ, Rolston JD, Molinaro AM, Clarke JL, Prados MD, Chang SM, Berger MS, DeSilva A, Butowski NA

Publication

Neuro-oncology

Publication ID (Profile URL)

https://researcherprofiles.org/profile/1178914

Publication Year

2014

PubMed ID

24670608

Publication Title

Han SJ, Rolston JD, Molinaro AM, Clarke JL, Prados MD, Chang SM, Berger MS, DeSilva A, Butowski NA. Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma. Neuro Oncol. 2014 Sep; 16(9):1255-62.